Paying for these new therapies, that may be curative for patients, remains a challenge.
Ashley Gallagher, MA
Advertisement
Ashley Gallagher is an assistant managing editor at Drug Topics®. She graduated in 2020 in journalism and mass communications and received her master’s degree in 2025 in digital journalism from St. Bonaventure University. Previously, she worked as a pharmacy technician for a retail chain.
Articles by Ashley Gallagher, MA
Advertisement
Advertisement
Advertisement
Trending on Drug Topics
1
Addressing Depression Symptoms Can Significantly Improve Asthma Outcomes
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
What the Newest Landmark PBM Reform Means for the Pharmacy Industry
4
TrumpRx Officially Launches, Introduces Drug Prices
5